Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivationTakako Inoue, Yasuhito Tanaka, Takanori Suzuki et al.|Journal of Hepatology|2021Cited by 110
Development of an in vivo delivery system for CRISPR/Cas9-mediated targeting of hepatitis B virus cccDNAMohammad Enamul Hoque Kayesh, Kyoko Tsukiyama–Kohara, Yutaka Amako et al.|Virus Research|2020Cited by 35